MiLaboratories
@milaboratories.bsky.social
Creators of MiXCR & Platforma: the leading software for the analysis of NGS data for immune profiling. Posting updates on software releases and new features.
Platforma.bio
Platforma.bio
Want to accelerate your antibody discovery workflow?
Join our webinar to learn how to prioritize lead candidates faster.
You’ll discover how to track enrichment and liabilities, monitor clone dynamics over time, and predict developability to minimize risk
Register here: bit.ly/4p8157W
Join our webinar to learn how to prioritize lead candidates faster.
You’ll discover how to track enrichment and liabilities, monitor clone dynamics over time, and predict developability to minimize risk
Register here: bit.ly/4p8157W
November 13, 2025 at 3:36 PM
Want to accelerate your antibody discovery workflow?
Join our webinar to learn how to prioritize lead candidates faster.
You’ll discover how to track enrichment and liabilities, monitor clone dynamics over time, and predict developability to minimize risk
Register here: bit.ly/4p8157W
Join our webinar to learn how to prioritize lead candidates faster.
You’ll discover how to track enrichment and liabilities, monitor clone dynamics over time, and predict developability to minimize risk
Register here: bit.ly/4p8157W
This week, we kicked off our Platforma Pioneers academic tour at UCLA!
Our hands-on workshop on how to accelerate no-code NGS data analysis with Platforma was a blast.
A big thank you to everyone who joined us—we loved seeing your curiosity and creativity in action!
🚗 Next stops - USC and UCSD!
Our hands-on workshop on how to accelerate no-code NGS data analysis with Platforma was a blast.
A big thank you to everyone who joined us—we loved seeing your curiosity and creativity in action!
🚗 Next stops - USC and UCSD!
November 12, 2025 at 2:46 PM
This week, we kicked off our Platforma Pioneers academic tour at UCLA!
Our hands-on workshop on how to accelerate no-code NGS data analysis with Platforma was a blast.
A big thank you to everyone who joined us—we loved seeing your curiosity and creativity in action!
🚗 Next stops - USC and UCSD!
Our hands-on workshop on how to accelerate no-code NGS data analysis with Platforma was a blast.
A big thank you to everyone who joined us—we loved seeing your curiosity and creativity in action!
🚗 Next stops - USC and UCSD!
RNA-seq to monitor minimal residual disease (MRD) in multiple myeloma?
A recent Nature study found that RNA-seq achieved higher sensitivity and stronger prognostic value than DNA-seq for MRD.
We're proud that MiXCR was the key tool in this study.
Read more here: x.com/MiLaboratori...
A recent Nature study found that RNA-seq achieved higher sensitivity and stronger prognostic value than DNA-seq for MRD.
We're proud that MiXCR was the key tool in this study.
Read more here: x.com/MiLaboratori...
November 6, 2025 at 12:42 PM
RNA-seq to monitor minimal residual disease (MRD) in multiple myeloma?
A recent Nature study found that RNA-seq achieved higher sensitivity and stronger prognostic value than DNA-seq for MRD.
We're proud that MiXCR was the key tool in this study.
Read more here: x.com/MiLaboratori...
A recent Nature study found that RNA-seq achieved higher sensitivity and stronger prognostic value than DNA-seq for MRD.
We're proud that MiXCR was the key tool in this study.
Read more here: x.com/MiLaboratori...
We just wrapped up two impactful days at the Cell Symposium in Sitges, Spain with Cellecta! Was great to be face-to-face with researchers: live demos of Platforma, learning more about what others are working on, and sharing what our teams have been building.
Thanks to everyone who stopped by!
Thanks to everyone who stopped by!
November 5, 2025 at 2:50 PM
We just wrapped up two impactful days at the Cell Symposium in Sitges, Spain with Cellecta! Was great to be face-to-face with researchers: live demos of Platforma, learning more about what others are working on, and sharing what our teams have been building.
Thanks to everyone who stopped by!
Thanks to everyone who stopped by!
Proud to share a new study advancing non-invasive immune monitoring in cancer. Researchers found tumor-derived TCR clonotypes enriched in cfDNA and persisting >50 weeks in circulating T cells.
Proud that MiXCR powered large-scale TCR sequencing across tumor, blood, and cfDNA.
#cfDNA #TCRseq #TCR
Proud that MiXCR powered large-scale TCR sequencing across tumor, blood, and cfDNA.
#cfDNA #TCRseq #TCR
October 30, 2025 at 11:44 AM
Big news: we’ve launched an interactive demo on the Platforma website!
Choose your own scientific adventure:
🔹 Antibody Discovery
🔹 Differential Gene Expression
🔹 Single Cell Multiomics
🔹 TCR/BCR Repertoire Analysis
👉 Dive into the demo here: shorturl.at/7tkD4
#NGS #Multiomics #TCR #BCR
Choose your own scientific adventure:
🔹 Antibody Discovery
🔹 Differential Gene Expression
🔹 Single Cell Multiomics
🔹 TCR/BCR Repertoire Analysis
👉 Dive into the demo here: shorturl.at/7tkD4
#NGS #Multiomics #TCR #BCR
October 28, 2025 at 8:06 AM
Big news: we’ve launched an interactive demo on the Platforma website!
Choose your own scientific adventure:
🔹 Antibody Discovery
🔹 Differential Gene Expression
🔹 Single Cell Multiomics
🔹 TCR/BCR Repertoire Analysis
👉 Dive into the demo here: shorturl.at/7tkD4
#NGS #Multiomics #TCR #BCR
Choose your own scientific adventure:
🔹 Antibody Discovery
🔹 Differential Gene Expression
🔹 Single Cell Multiomics
🔹 TCR/BCR Repertoire Analysis
👉 Dive into the demo here: shorturl.at/7tkD4
#NGS #Multiomics #TCR #BCR
🧬 Join our team: We’re hiring a Scientific Sales Development Representative in Bilbao!
Who you are: Degree in Biology/Bioinformatics (or similar), strong English, 0–2 years’ experience
lnkd.in/dxMXRT84
Who you are: Degree in Biology/Bioinformatics (or similar), strong English, 0–2 years’ experience
lnkd.in/dxMXRT84
MiLaboratories hiring Scientific Sales Development Representative in Bilbao, Basque Country, Spain | LinkedIn
Posted 11:04:05 AM. TL;DR🧬 NGS data analysis platform for biologists🚀 Backed by Speedinvest and K Fund among others —…See this and similar jobs on LinkedIn.
lnkd.in
October 27, 2025 at 6:45 PM
🧬 Join our team: We’re hiring a Scientific Sales Development Representative in Bilbao!
Who you are: Degree in Biology/Bioinformatics (or similar), strong English, 0–2 years’ experience
lnkd.in/dxMXRT84
Who you are: Degree in Biology/Bioinformatics (or similar), strong English, 0–2 years’ experience
lnkd.in/dxMXRT84
🔬 Empowering the next generation of scientists!
Today, our team hosted a hands-on Platforma workshop at the University of Navarra, where researchers explored Platforma's powerful functionalities hands on with real datasets.
Thanks to everyone who joined!
#bioinformatics #NGS
Today, our team hosted a hands-on Platforma workshop at the University of Navarra, where researchers explored Platforma's powerful functionalities hands on with real datasets.
Thanks to everyone who joined!
#bioinformatics #NGS
October 23, 2025 at 1:18 PM
🔬 Empowering the next generation of scientists!
Today, our team hosted a hands-on Platforma workshop at the University of Navarra, where researchers explored Platforma's powerful functionalities hands on with real datasets.
Thanks to everyone who joined!
#bioinformatics #NGS
Today, our team hosted a hands-on Platforma workshop at the University of Navarra, where researchers explored Platforma's powerful functionalities hands on with real datasets.
Thanks to everyone who joined!
#bioinformatics #NGS
🔬 Transform your B-cell research with Platforma - no coding required:
✔️ Annotate & build clonotypes with quality controls
✔️ Run clonality analyses across studies & patient groups
✔️ Cluster B cells, perform differential analysis, & explore UMAP
bit.ly/42QDhNb
Download today: platforma.bio
✔️ Annotate & build clonotypes with quality controls
✔️ Run clonality analyses across studies & patient groups
✔️ Cluster B cells, perform differential analysis, & explore UMAP
bit.ly/42QDhNb
Download today: platforma.bio
BCR Repertoire Analysis | Antibody Clonotypes & Diversity with Platforma
YouTube video by MiLaboratories
www.youtube.com
October 22, 2025 at 9:52 AM
🔬 Transform your B-cell research with Platforma - no coding required:
✔️ Annotate & build clonotypes with quality controls
✔️ Run clonality analyses across studies & patient groups
✔️ Cluster B cells, perform differential analysis, & explore UMAP
bit.ly/42QDhNb
Download today: platforma.bio
✔️ Annotate & build clonotypes with quality controls
✔️ Run clonality analyses across studies & patient groups
✔️ Cluster B cells, perform differential analysis, & explore UMAP
bit.ly/42QDhNb
Download today: platforma.bio
Although we couldn’t make it to #ASHG2025, our partner Illumina presented a fantastic study on accurate full-length V(D)J clonotype detection using high-quality long reads on the MiSeq™ i100.
We’re especially proud that MiXCR was used to enable precise immune repertoire profiling.
We’re especially proud that MiXCR was used to enable precise immune repertoire profiling.
October 17, 2025 at 8:36 AM
Although we couldn’t make it to #ASHG2025, our partner Illumina presented a fantastic study on accurate full-length V(D)J clonotype detection using high-quality long reads on the MiSeq™ i100.
We’re especially proud that MiXCR was used to enable precise immune repertoire profiling.
We’re especially proud that MiXCR was used to enable precise immune repertoire profiling.
A major leap forward in treatment for Addison’s Disease!
In a new publication from bioRxiv, researchers pinpointed IFN-γ–producing self-reactive CD4+ T cells as the main drivers of autoimmune adrenalitis in a mouse model.
We're proud that MiXCR enabled analysis of TCR clonotypes from scRNAseq.
In a new publication from bioRxiv, researchers pinpointed IFN-γ–producing self-reactive CD4+ T cells as the main drivers of autoimmune adrenalitis in a mouse model.
We're proud that MiXCR enabled analysis of TCR clonotypes from scRNAseq.
October 16, 2025 at 11:12 AM
A major leap forward in treatment for Addison’s Disease!
In a new publication from bioRxiv, researchers pinpointed IFN-γ–producing self-reactive CD4+ T cells as the main drivers of autoimmune adrenalitis in a mouse model.
We're proud that MiXCR enabled analysis of TCR clonotypes from scRNAseq.
In a new publication from bioRxiv, researchers pinpointed IFN-γ–producing self-reactive CD4+ T cells as the main drivers of autoimmune adrenalitis in a mouse model.
We're proud that MiXCR enabled analysis of TCR clonotypes from scRNAseq.
Gene expression analysis with bulk RNA-seq data traditionally involves many steps (preprocessing, differential expression, pathway enrichment) + bioinformatics expertise
Platforma changes that.
Watch how we perform gene expression analysis in just a few clicks.
www.youtube.com/watch?v=K7aq...
Platforma changes that.
Watch how we perform gene expression analysis in just a few clicks.
www.youtube.com/watch?v=K7aq...
Differential Gene Expression Analysis | Bulk RNA-seq Pipeline in Platforma
YouTube video by MiLaboratories
www.youtube.com
October 15, 2025 at 11:56 AM
Gene expression analysis with bulk RNA-seq data traditionally involves many steps (preprocessing, differential expression, pathway enrichment) + bioinformatics expertise
Platforma changes that.
Watch how we perform gene expression analysis in just a few clicks.
www.youtube.com/watch?v=K7aq...
Platforma changes that.
Watch how we perform gene expression analysis in just a few clicks.
www.youtube.com/watch?v=K7aq...
New Case Study featuring MiXCR + Qiagen: University of Antwerp pioneers “celluloepidemiology", revealing infections missed by antibodies and unique signatures linked to long COVID.
Find out how they scaled TCR profiling for population-level insights and cut prep time by 25%.
bit.ly/498lvsu
Find out how they scaled TCR profiling for population-level insights and cut prep time by 25%.
bit.ly/498lvsu
Case Study: How University of Antwerp differentiated COVID-19 disease severity with T Cell signatures
Discover how MiXCR + QIAGEN streamline TCR sequencing and accelerate breakthroughs in immune research
bit.ly
October 14, 2025 at 7:29 AM
New Case Study featuring MiXCR + Qiagen: University of Antwerp pioneers “celluloepidemiology", revealing infections missed by antibodies and unique signatures linked to long COVID.
Find out how they scaled TCR profiling for population-level insights and cut prep time by 25%.
bit.ly/498lvsu
Find out how they scaled TCR profiling for population-level insights and cut prep time by 25%.
bit.ly/498lvsu
You might know us as the creators of MiXCR, and now we've launched Platforma for more powerful downstream functionalities without the coding bottleneck.
#NGS #singlecell #VDJ #bioinformatics
#NGS #singlecell #VDJ #bioinformatics
🚀 Platforma – no-code bioinformatic analysis
Say goodbye to coding! 🧬 Analyze NGS data of any species with ease, from gene expression to VDJ and single-cell workflows.
💻 Download it for free 👉 platforma.bio
@milaboratories.bsky.social
Say goodbye to coding! 🧬 Analyze NGS data of any species with ease, from gene expression to VDJ and single-cell workflows.
💻 Download it for free 👉 platforma.bio
@milaboratories.bsky.social
October 13, 2025 at 2:43 PM
You might know us as the creators of MiXCR, and now we've launched Platforma for more powerful downstream functionalities without the coding bottleneck.
#NGS #singlecell #VDJ #bioinformatics
#NGS #singlecell #VDJ #bioinformatics
Congratulations to Nobel Laureate Shimon Sakaguchi for his groundbreaking work on regulatory T cells! 🧬
We're proud to see our technology, MiXCR, supporting his lab’s research. In a recent study, MiXCR helped the team decode TCR repertoires.
Proud to support science that changes the world. 🌍
We're proud to see our technology, MiXCR, supporting his lab’s research. In a recent study, MiXCR helped the team decode TCR repertoires.
Proud to support science that changes the world. 🌍
October 8, 2025 at 8:25 AM
Congratulations to Nobel Laureate Shimon Sakaguchi for his groundbreaking work on regulatory T cells! 🧬
We're proud to see our technology, MiXCR, supporting his lab’s research. In a recent study, MiXCR helped the team decode TCR repertoires.
Proud to support science that changes the world. 🌍
We're proud to see our technology, MiXCR, supporting his lab’s research. In a recent study, MiXCR helped the team decode TCR repertoires.
Proud to support science that changes the world. 🌍
Biologists design brilliant experiments...then lose momentum waiting for results.
That’s why we built Platforma, to put the power of analysis directly into biologists’ hands.
🎥 Watch the demo to see how Platforma takes you from raw data to validated T-cell insights, without any coding.
That’s why we built Platforma, to put the power of analysis directly into biologists’ hands.
🎥 Watch the demo to see how Platforma takes you from raw data to validated T-cell insights, without any coding.
October 7, 2025 at 7:34 AM
Biologists design brilliant experiments...then lose momentum waiting for results.
That’s why we built Platforma, to put the power of analysis directly into biologists’ hands.
🎥 Watch the demo to see how Platforma takes you from raw data to validated T-cell insights, without any coding.
That’s why we built Platforma, to put the power of analysis directly into biologists’ hands.
🎥 Watch the demo to see how Platforma takes you from raw data to validated T-cell insights, without any coding.
October is Breast Cancer Awareness Month, a timely moment to spotlight new advances in how we understand and treat this disease. 🎗️
A recently study explores dynamic systemic immune responses in early-stage HR+ patients receiving chemotherapy + immunotherapy.
Read more here: shorturl.at/jOQkO
A recently study explores dynamic systemic immune responses in early-stage HR+ patients receiving chemotherapy + immunotherapy.
Read more here: shorturl.at/jOQkO
October 2, 2025 at 1:18 PM
October is Breast Cancer Awareness Month, a timely moment to spotlight new advances in how we understand and treat this disease. 🎗️
A recently study explores dynamic systemic immune responses in early-stage HR+ patients receiving chemotherapy + immunotherapy.
Read more here: shorturl.at/jOQkO
A recently study explores dynamic systemic immune responses in early-stage HR+ patients receiving chemotherapy + immunotherapy.
Read more here: shorturl.at/jOQkO
Fast insights from single-cell data without coding
With Platforma, you can:
🔹 Explore UMAPs & Leiden clusters
🔹 Integrate transcriptomics + VDJ metrics
🔹 Visualize clonotypes & sequence similarities
🔹 Overlay gene expression across clusters
🎥 youtu.be/FrsS3YDauhg
#singlecell #VDJ #NGS
With Platforma, you can:
🔹 Explore UMAPs & Leiden clusters
🔹 Integrate transcriptomics + VDJ metrics
🔹 Visualize clonotypes & sequence similarities
🔹 Overlay gene expression across clusters
🎥 youtu.be/FrsS3YDauhg
#singlecell #VDJ #NGS
Single-Cell Multi-Omics Analysis | UMAP, Clustering & Gene Expression in Platforma
YouTube video by MiLaboratories
youtu.be
September 30, 2025 at 8:53 AM
Fast insights from single-cell data without coding
With Platforma, you can:
🔹 Explore UMAPs & Leiden clusters
🔹 Integrate transcriptomics + VDJ metrics
🔹 Visualize clonotypes & sequence similarities
🔹 Overlay gene expression across clusters
🎥 youtu.be/FrsS3YDauhg
#singlecell #VDJ #NGS
With Platforma, you can:
🔹 Explore UMAPs & Leiden clusters
🔹 Integrate transcriptomics + VDJ metrics
🔹 Visualize clonotypes & sequence similarities
🔹 Overlay gene expression across clusters
🎥 youtu.be/FrsS3YDauhg
#singlecell #VDJ #NGS
A new study from @ox.ac.uk shows why HR+ patients with lymph node metastasis fare worse:
- Weakened Defense: Tumor-reactive CD8 T cells are scarce, impairing cancer surveillance.
- Early-Stage Window: Early HR+ patients have a robust, diverse circulating CD8 TCR
More details: shorturl.at/0HP2l
- Weakened Defense: Tumor-reactive CD8 T cells are scarce, impairing cancer surveillance.
- Early-Stage Window: Early HR+ patients have a robust, diverse circulating CD8 TCR
More details: shorturl.at/0HP2l
September 25, 2025 at 1:17 PM
A new study from @ox.ac.uk shows why HR+ patients with lymph node metastasis fare worse:
- Weakened Defense: Tumor-reactive CD8 T cells are scarce, impairing cancer surveillance.
- Early-Stage Window: Early HR+ patients have a robust, diverse circulating CD8 TCR
More details: shorturl.at/0HP2l
- Weakened Defense: Tumor-reactive CD8 T cells are scarce, impairing cancer surveillance.
- Early-Stage Window: Early HR+ patients have a robust, diverse circulating CD8 TCR
More details: shorturl.at/0HP2l
We’re thrilled to team up with @yefis-immunology.bsky.social for our next webinar!
📅 October 7th, 16:00 CET
Platforma was built to make cutting-edge bioinformatics accessible to every scientist, so anyone can turn raw NGS into meaningful insights without coding.
🔗 Register here: shorturl.at/AQtCD
📅 October 7th, 16:00 CET
Platforma was built to make cutting-edge bioinformatics accessible to every scientist, so anyone can turn raw NGS into meaningful insights without coding.
🔗 Register here: shorturl.at/AQtCD
September 24, 2025 at 7:45 AM
We’re thrilled to team up with @yefis-immunology.bsky.social for our next webinar!
📅 October 7th, 16:00 CET
Platforma was built to make cutting-edge bioinformatics accessible to every scientist, so anyone can turn raw NGS into meaningful insights without coding.
🔗 Register here: shorturl.at/AQtCD
📅 October 7th, 16:00 CET
Platforma was built to make cutting-edge bioinformatics accessible to every scientist, so anyone can turn raw NGS into meaningful insights without coding.
🔗 Register here: shorturl.at/AQtCD
Last week we hosted a webinar with Kiel University and shared valuable insights on T-cell responses against EBV (Epstein–Barr Virus) and its implications for advancing research and therapeutic development.
Weren't able to attend?
🎥 Watch the recording here: www.youtube.com/watch?v=l2Q8...
Weren't able to attend?
🎥 Watch the recording here: www.youtube.com/watch?v=l2Q8...
September 23, 2025 at 12:20 PM
Last week we hosted a webinar with Kiel University and shared valuable insights on T-cell responses against EBV (Epstein–Barr Virus) and its implications for advancing research and therapeutic development.
Weren't able to attend?
🎥 Watch the recording here: www.youtube.com/watch?v=l2Q8...
Weren't able to attend?
🎥 Watch the recording here: www.youtube.com/watch?v=l2Q8...
💡Why repertoire clonality matters and how to analyze it
Done right, repertoire analysis transforms sequencing data into actionable insights for immune monitoring and therapy evaluation.
bit.ly/4gBZlRp
Done right, repertoire analysis transforms sequencing data into actionable insights for immune monitoring and therapy evaluation.
bit.ly/4gBZlRp
How to Analyze TCR/BCR Repertoire Diversity and Clonality
Learn what immune repertoire diversity is, key clonality metrics, why downsampling matters, and how to visualize TCR/BCR repertoires for immune profiling.
open.substack.com
September 23, 2025 at 7:06 AM
💡Why repertoire clonality matters and how to analyze it
Done right, repertoire analysis transforms sequencing data into actionable insights for immune monitoring and therapy evaluation.
bit.ly/4gBZlRp
Done right, repertoire analysis transforms sequencing data into actionable insights for immune monitoring and therapy evaluation.
bit.ly/4gBZlRp
Location, location, location.
Developing a multimodal framework, new research from @bcmhouston.bsky.social reveals that a T cell's location within a tumor is a major factor influencing its function.
We're proud that MiXCR enabled comprehensive TCR repertoire profiling in this study.
Developing a multimodal framework, new research from @bcmhouston.bsky.social reveals that a T cell's location within a tumor is a major factor influencing its function.
We're proud that MiXCR enabled comprehensive TCR repertoire profiling in this study.
September 18, 2025 at 9:20 AM
Location, location, location.
Developing a multimodal framework, new research from @bcmhouston.bsky.social reveals that a T cell's location within a tumor is a major factor influencing its function.
We're proud that MiXCR enabled comprehensive TCR repertoire profiling in this study.
Developing a multimodal framework, new research from @bcmhouston.bsky.social reveals that a T cell's location within a tumor is a major factor influencing its function.
We're proud that MiXCR enabled comprehensive TCR repertoire profiling in this study.
Prioritizing antibody candidates shouldn’t require coding bioinformatics expertise. With Platforma, biologists in academia or pharma can analyze NGS data independently, explore motifs, predict liabilities, and select the best antibody leads with confidence.
#antibody #bcr #bioinformatics
#antibody #bcr #bioinformatics
September 17, 2025 at 2:18 PM
Prioritizing antibody candidates shouldn’t require coding bioinformatics expertise. With Platforma, biologists in academia or pharma can analyze NGS data independently, explore motifs, predict liabilities, and select the best antibody leads with confidence.
#antibody #bcr #bioinformatics
#antibody #bcr #bioinformatics
🚨 Last chance to register!
We’re going live tomorrow to explore the link between Epstein-Barr Virus (EBV) and Primary Sclerosing Cholangitis (PSC) with insights from large-scale immune profiling.
📅 Wednesday, Sep 17 @ 3:00 PM GMT+2
💻 Live demo included
Register here: shorturl.at/E4tpj
We’re going live tomorrow to explore the link between Epstein-Barr Virus (EBV) and Primary Sclerosing Cholangitis (PSC) with insights from large-scale immune profiling.
📅 Wednesday, Sep 17 @ 3:00 PM GMT+2
💻 Live demo included
Register here: shorturl.at/E4tpj
Interactive Session with the Research Team: T and B Cell Responses Against Epstein-Barr Virus in PSC · Zoom · Luma
Join us for an exclusive interactive session with the authors of the groundbreaking Nature Medicine article, "T and B cell responses against Epstein-Barr virus…
shorturl.at
September 16, 2025 at 9:00 AM
🚨 Last chance to register!
We’re going live tomorrow to explore the link between Epstein-Barr Virus (EBV) and Primary Sclerosing Cholangitis (PSC) with insights from large-scale immune profiling.
📅 Wednesday, Sep 17 @ 3:00 PM GMT+2
💻 Live demo included
Register here: shorturl.at/E4tpj
We’re going live tomorrow to explore the link between Epstein-Barr Virus (EBV) and Primary Sclerosing Cholangitis (PSC) with insights from large-scale immune profiling.
📅 Wednesday, Sep 17 @ 3:00 PM GMT+2
💻 Live demo included
Register here: shorturl.at/E4tpj